Le programme de FOCUS 2024 meets Canada est disponible : focus-meeting.fr > Innovation et optimisation de nos stratégies en onco-urologie #radiothérapie #oncologie #médecinenucléaire #urologie Sous la présidence de Bladou Franck et Wes Kassouf 10 et 11 octobre #toulouse

Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype mu… pubmed.ncbi.nlm.nih.gov/38860746/

🚩Do not miss these #CUA24 Educational Sessions featuring Wes Kassouf Nimira Alimohamed Maria Jiang Urban Emmenegger Frederic Pouliot 🍽️Food service included.🚩Reserve your spot today >>> cuameeting.org/extra-credits/ #urothelialcarcinoma #RadioligandTherapy

Clinical Validation of the Intermediate-risk NMIBC Scoring System and Substratification Model Proposed by the IBCG (International Bladder Cancer Group): A Multicenter YAU Urothelial Working Group Collaboration European Urology Oncology Paolo Gontero francesco soria authors.elsevier.com/c/1jIAG9Cfv--d… a🧵

Positive results from the NIAGARA Phase III trial showed durvalumab with neoadjuvant chemo then cystectomy had a statistically significant and clinically meaningful improvement in EFS & OS versus chemo/cystectomy alone in muscle invasive bladder cancer astrazeneca.com/media-centre/p…

Published !!! in Cancer Immunology Research pubmed.ncbi.nlm.nih.gov/38916567/ This study led by two amazing students, Priyanka Yolmo and Sadaf Rahimi , shows the influence of atypical B cells & TLSs in response to #BCG. Thx to all co-authors at Sinclair Cancer Research Institute and funding Cancer Research Society & BladderCancerCanada !! 1/7

🚩Do not miss these #CUA24 Educational Sessions featuring Wes Kassouf Nimira Alimohamed Maria Jiang Urban Emmenegger Frederic Pouliot 🍽️Food service included.🚩Reserve your spot today >>> cuameeting.org/extra-credits/ #urothelialcarcinoma #RadioligandTherapy

CUA Guidelines are moving to GRADE! Amazing workshop led by Rod Breau Philippe Violette Philipp Dahm Adriana Modica and Canadian Urological Association yesterday to get us all up to speed. Exciting times ahead 🎉 #CUA24

Great to catchup with present and past #urology McGill residents #cua2024 ⁦McGill University⁩ Canadian Urological Association⁩ ⁦Melanie AP⁩

The Faltas lab is seeking postdoctoral candidates. Details and contact information below. Please spread the word and retweet.

Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer by Yuzhen Zhou Full article: buff.ly/45RiXvk Vince D’Andrea, MD Raie Bekele joaquim bellmunt Kent Mouw #Medtwitter #UroSoMe #BladderCancer

SURS-FTS 2024…Join us for a unique meeting combining Focal Therapy, Robotics, Imaging and AI this upcoming September. Do not hesitate to share your work! All you would need to know to enhance your practice in one single gathering! Focal Therapy Society Endourological Society Amer. Urol. Assn.

🎒✏️🍎Back to school & back to work! We are happy to share these ESMO - Eur. Oncology highlights with you so please be sure to plan your September! 🍂 ➡️For more info and to register > cua.org/event/33193 Wes Kassouf Aly-Khan Lalani

Great minds at work coming up w/ consensus on tough Qs in Bladderca IBCG #IBCG24 Joan Palou Redorta splernerMD Jonathan Rosenberg MD Petros Grivas Laura S. Mertens Ashish M. Kamat, MD, MBBS Roger Li Wes Kassouf Sia Daneshmand, M.D. Philippe spiess Andrea Necchi Sarah P. Psutka MD MS

Really important and been saying this for many years so good to see other sources supporting. Extent of debulking prognostic but not therapeutic nor practiced in other cancers. Pts in BC2001 with biopsy only did no differently to those with resections

Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG) sciencedirect.com/science/articl… European Urology Oncology IBCG